+86-0635-6175299

Company Details

Shandong Haohong Biotechnology Co., Ltd.

[Shandong,China]

Business Type:Manufacturer

Main Markets: Americas , Asia , East Europe , Europe , Middle East , North Europe , West Europe , Worldwide

Exporter:71% - 80%

Certs:Test Report, ISO9001
Language

Shandong Haohong Biotechnology Co., Ltd.

 HomeNewsSupply of high-quality Rivaroxaban API and Intermediates

Supply of high-quality Rivaroxaban API and Intermediates

2021-09-08

What is Rivaroxaban?

Rivaroxaban is a new oral anticoagulant used in adult patients with non valvular atrial fibrillation (except atrial fibrillation caused by rheumatic heart valve disease and atrial fibrillation after heart valve replacement) to reduce the risk of stroke and systemic embolism.

Shandong Haohong Biotechnology Co., Ltd is mainly focuses on the development of anti-cancer, anti-diabets series of API and its advanced intermediates. The main products include Bicalutamide, enzalutamide, apalutamide, macitentan, cabozantinib, ceritinib, empagliflozin, Rivaroxaban, and alectinib,etc. In line with the concept of "truth-seeking, innovation and integrity", we had exported our products to the United States, European countries, Japan, India, Bangladesh and other overseas markets. At present, Our company has dozens of advanced intermediates, all of which are commercialized.

Rivaroxaban API And Intermediates has always been one of the main products promoted by our company.The product purity is at least 99%.We can offer best quality product with perfect service, full documents support, factory audit is availbale.

Our Rivaroxaban API and Intermediates list is as following, we have all the below intermedites offering all year.

rivaroxaban

If you want to know more information about our company and products, please visit our website at http://www.haohongpharma.com. We will offer the best price and the best quality for you.

Previous: Supply of high-quality Apixaban API and Intermediates

Next: FDA Approves Updated Indication for Merck`s KEYTRUDA® (pembrolizumab) for Treatment of Certain Patients With Urothelial Carcinoma (Bladder Cancer)

 HomeNewsSupply of high-quality Rivaroxaban API and Intermediates

Shandong Haohong Biotechnology Co., Ltd.